Vanberra Signal

MS Pen Technologies

Curated by Signal

Provider of a mass spectrometry-based cancer detection and diagnosis system

Overview

Provider of a mass spectrometry-based cancer detection and diagnosis system. The company offers "MasSpec Pen" that directly connects to medical mass spectrometers and combines the power of mass spectrometry, and artificial intelligence to provide real-time decision-making for surgeons, oncologists, and healthcare providers. The device has been used to analyze human tissue biopsies, including normal and cancerous breast, lung, ovarian, and thyroid samples.

Key facts

Founded
2019

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Imaging supplies and accessories for radiology suites

    Life Sciences TechnologyCaledonia, United States
  • Provider of whole-genome sequencing analysis for health and wellness

    Life Sciences TechnologyNew York City, United States
  • Developer of visualization system for surgeries

    Life Sciences TechnologySeattle, United States

About MS Pen Technologies

What does MS Pen Technologies do?

Provider of a mass spectrometry-based cancer detection and diagnosis system.

Where is MS Pen Technologies headquartered?

MS Pen Technologies is headquartered in Houston, United States.

When was MS Pen Technologies founded?

MS Pen Technologies was founded in 2019.

Which sector is MS Pen Technologies in?

MS Pen Technologies operates in Life Sciences Technology.

Who are MS Pen Technologies's competitors?

Companies similar to MS Pen Technologies include Cone Instruments, Dante Labs, and Proprio.